Response to ALK-1 inhibitors has also been reported in KIF5B-ALK1 histiocytosis identified in two adults with liver and skin involvement (10) and with the case who had CNS involvement with systemic disease (9). This evidence concerns the gene KIF5B and Histiocytosis.